Home Profiles Health Care Equipment & Supplies

Fisher & Paykel Healthcare Corporation Limited (ASX FPH)

Name
Fisher & Paykel Healthcare Corporation Limited
Exchange
ASX
Code
ASX FPH
Industry
Health Care Equipment & Supplies
GICS
351010
Sub-Industry
Health Care Equipment
GICS
35101010

Search for a different stock profile

 

What we think of Fisher & Paykel Healthcare Corporation Limited

Fisher & Paykel Healthcare (ASX FPH) designs, manufactures and markets medical devices and accessories for use in respiratory care, acute care, and the treatment of obstructive sleep apnoea. The company is the leading global supplier of humidification solutions in the hospital ICU and is also a major player in the obstructive sleep apnoea space. Headquartered in New Zealand, the company generates more than 99% of its sales from international markets.

Read our full report on Fisher & Paykel Healthcare Corporation Limited




Fisher & Paykel Healthcare Corporation Limited (ASX FPH) Ratios

30/09/2018
30/06/2018
31/12/2017
30/06/2017
31/12/2016
30/06/2016
Growth of Net Sales (%)
11.54
11.54
9.06
7.81
10.29
11.61
Growth of EBITDA (%)
15.45
15.45
10.53
6.05
14.43
17.08
Growth of EBIT (%)
20.87
20.87
9.69
3.88
14.53
16.28
Growth of Earning before Tax (%)
19.11
19.11
9.21
2.61
22.53
31.47
Growth of Net Income (%)
19.80
19.80
9.74
3.96
20.41
26.05
Growth of Free Cash Flow (%)
22.09
22.09
25.89
25.80
6.38
2.17
Return on Fixed Assets (%)
40.00
40.00
40.15
38.08
40.48
40.23
Return on Total Assets (%)
17.57
17.57
16.85
16.53
17.77
17.97
Return on Total Equity (%)
26.61
26.61
25.44
25.46
27.41
30.14
Return on Capital Employed (%)
21.11
21.11
20.46
20.10
21.91
22.68
EBITDA Margin (%)
31.27
31.27
31.22
30.21
30.80
30.71
EBIT Margin (%)
27.19
27.19
26.74
25.09
26.58
26.03
Pre-tax income/Sales (%)
26.58
26.58
26.54
24.89
26.50
26.15
After Tax income/Sales (%)
19.05
19.05
18.86
17.74
18.75
18.39
Net Profit Margin (%)
19.05
19.05
18.86
17.74
18.75
18.39
R & D To Sales
0.09
0.09
0.10
0.10
0.10
0.10
Sales To Cash
18.43
18.43
30.08
15.41
14.35
47.24
Sales to Accounts Receivable
6.73
6.73
7.51
6.93
7.62
7.00
Sales to Inventory
7.55
7.55
7.65
6.29
6.52
6.41
Sales to Working Capital
6.29
6.29
6.25
5.34
5.88
5.78
Asset Turnover
1.03
1.03
1.01
1.05
1.07
1.10
Quick Ratio
1.35
1.35
1.57
1.28
1.33
1.08
Cash Ratio
0.28
0.28
0.18
0.39
0.42
0.14
Current Ratio
2.08
2.08
2.38
2.37
2.40
2.27
Days In inventory
151.15
151.15
146.65
163.18
154.57
158.88
Inventory Turnover
2.41
2.41
2.49
2.24
2.36
2.30
Days In Accounts Payable
126.63
135.38
36.35
102.02
37.68
107.48
Days In Cash
49.99
49.99
30.73
57.85
65.11
19.88
Days in Receivables
50.72
50.72
46.26
50.50
48.05
54.06
Total Debt / Equity
0.12
0.12
0.11
0.13
0.09
0.11
Net Debt / Equity
-0.02
-0.02
-0.07
0.04
0.00
0.08
Goodwill & Intangibles / Total Assets
0.05
0.05
0.05
0.05
0.05
0.05
Net Debt / Total assets
-0.01
-0.01
-0.05
0.03
0.00
0.06
Total Debt / Total Assets
0.09
0.09
0.08
0.09
0.07
0.08
Total Equity / Total Assets
0.74
0.74
0.74
0.74
0.75
0.73
Net Debt / EBITDA
-0.05
-0.05
-0.17
0.10
0.00
0.19
Interest Cover (EBIT)
99.29
99.29
69.96
63.89
61.54
50.32
Payout Ratio
0.65
0.65
0.55
0.71
0.52
0.62
Retention ratio
0.43
0.43
0.37
0.39
0.37
0.40

Fisher & Paykel Healthcare Corporation Limited (ASX FPH) Industry Comparison

Fisher & Paykel H.
Health Care Equipment & Supplies
Difference
Health Care Equipment
Difference
Growth of Net Sales (%)
11.54
13.22
-12.69%
10.02
15.18%
Growth of EBITDA (%)
15.45
41.87
-63.10%
16.59
-6.84%
Growth of EBIT (%)
20.87
47.60
-56.15%
19.86
5.07%
Growth of Earning before Tax (%)
19.11
52.45
-63.58%
17.75
7.64%
Growth of Net Income (%)
19.80
61.40
-67.75%
58.91
-66.38%
Growth of Free Cash Flow (%)
22.09
44.37
-50.22%
50.97
-56.66%
Return on Fixed Assets (%)
40.00
132.24
-69.75%
118.03
-66.11%
Return on Total Assets (%)
17.57
12.02
46.22%
17.78
-1.18%
Return on Total Equity (%)
26.61
22.39
18.87%
30.56
-12.91%
Return on Capital Employed (%)
21.11
15.33
37.76%
23.93
-11.75%
EBITDA Margin (%)
31.27
25.37
23.27%
30.72
1.81%
EBIT Margin (%)
27.19
21.97
23.76%
25.62
6.11%
Pre-tax income/Sales (%)
26.58
21.79
21.99%
24.78
7.24%
After Tax income/Sales (%)
19.05
15.78
20.72%
18.64
2.22%
Net Profit Margin (%)
19.05
15.76
20.85%
18.64
2.22%
R & D To Sales
0.09
0.08
7.39%
0.09
-4.50%
Sales To Cash
18.43
10.98
67.81%
16.75
9.98%
Sales to Accounts Receivable
6.73
6.16
9.23%
5.63
19.45%
Sales to Inventory
7.55
6.92
9.16%
7.96
-5.15%
Sales to Working Capital
6.29
5.83
7.87%
6.26
0.44%
Asset Turnover
1.03
0.84
23.28%
1.10
-5.61%
Quick Ratio
1.35
2.58
-47.70%
1.34
0.40%
Cash Ratio
0.28
1.61
-82.42%
0.30
-6.22%
Current Ratio
2.08
3.53
-41.17%
2.12
-2.06%
Days In inventory
151.15
151.45
-0.20%
165.50
-8.67%
Inventory Turnover
2.41
2.50
-3.42%
2.63
-8.35%
Days In Accounts Payable
126.63
87.16
45.28%
129.90
-2.52%
Days In Cash
49.99
232.07
-78.46%
56.01
-10.74%
Days in Receivables
50.72
58.70
-13.59%
72.39
-29.93%
Total Debt / Equity
0.12
0.28
-55.75%
0.33
-62.48%
Net Debt / Equity
-0.02
0.01
-407.26%
0.21
-109.10%
Goodwill & Intangibles / Total Assets
0.05
0.27
-80.84%
0.31
-83.02%
Net Debt / Total assets
-0.01
-0.05
-69.41%
0.11
-113.48%
Total Debt / Total Assets
0.09
0.15
-40.62%
0.18
-48.37%
Total Equity / Total Assets
0.74
0.65
15.28%
0.59
25.81%
Net Debt / EBITDA
-0.05
-0.31
-85.08%
0.51
-108.99%
Interest Cover (EBIT)
99.29
55.59
78.61%
61.70
60.91%
Payout Ratio
0.65
0.54
21.55%
0.68
-4.88%
Retention ratio
0.43
0.51
-16.15%
0.42
0.66%

Fisher & Paykel Healthcare Corporation Limited (ASX FPH) Balance Sheet

30/09/2018
30/06/2018
31/12/2017
30/06/2017
31/12/2016
30/06/2016
Total Cash And Short Term Investments ($m)
101.57
101.51
120.51
56.77
59.22
17.23
Cash And Equivalents ($m)
50.87
50.84
28.99
56.77
59.03
17.23
Short Term Investments ($m)
50.69
50.66
91.25
-
-
-
Total Receivables ($m)
140.25
140.17
134.24
129.18
126.72
118.81
Accounts Receivable ($m)
139.33
139.25
116.15
126.13
111.13
116.28
Other Receivables ($m)
0.92
0.92
18.09
3.05
15.60
2.53
Inventory ($m)
124.12
124.04
113.97
139.01
130.00
127.04
Other Current Assets, Total ($m)
6.60
6.60
16.81
19.46
20.22
22.91
Total Current Assets ($m)
372.53
372.31
385.53
344.43
336.17
285.99
Net Property Plant And Equipment ($m)
474.37
474.09
432.97
435.45
409.45
380.47
Other Intangibles ($m)
50.32
50.29
45.81
45.70
42.85
38.78
Other Assets, Total ($m)
59.77
59.73
66.53
65.36
56.62
65.20
Deferred Tax Assets Long Term ($m)
37.03
37.01
31.54
35.21
31.68
30.69
Other Long Term Assets ($m)
22.73
22.72
34.99
30.15
24.94
34.51
Total Assets ($m)
956.99
956.42
931.66
890.93
845.67
770.44
Accounts Payable ($m)
105.23
105.17
29.72
101.52
28.21
92.52
Short-term Borrowings ($m)
19.52
19.51
14.63
22.61
15.12
16.70
Current Portion of Long Term Debt/Capital Leases ($m)
26.95
26.93
12.63
1.81
5.68
2.06
Other Current Liabilities, Total ($m)
27.50
27.48
65.71
19.65
53.25
14.63
Current Income Taxes Payable ($m)
9.90
9.89
19.99
10.21
14.16
7.13
Other Current Liabilities ($m)
17.60
17.59
45.71
9.45
39.10
7.50
Total Current Liabilities ($m)
179.21
179.10
162.14
145.59
140.21
125.91
Long Term Debt ($m)
41.52
41.50
47.90
57.53
38.81
45.50
Other Liabilities, Total ($m)
24.29
24.28
29.63
32.15
29.56
34.37
Deferred Tax Liability Non Current ($m)
7.70
7.70
15.63
14.98
14.83
15.90
Other Non Current Liabilities ($m)
16.59
16.58
6.73
17.17
7.90
18.47
Total Liabilities ($m)
245.02
244.88
239.66
235.28
208.58
205.79
Total Common Equity ($m)
711.97
711.54
691.99
655.65
637.09
564.65
Common Stock & APIC ($m)
195.52
195.41
183.04
185.67
176.70
168.39
Retained Earnings ($m)
452.19
451.92
424.70
389.65
376.52
331.97
Treasury Stock & Other ($m)
64.26
64.22
84.25
80.33
83.87
64.29
Total Equity ($m)
711.97
711.54
691.99
655.65
637.09
564.65
Total Liabilities And Equity ($m)
956.99
956.42
931.66
890.93
845.67
770.44
Trading Asset Securities
-
-
0.27
-
0.19
-
Gross Property Plant And Equipment
-
-
653.82
-
644.41
-
Accumulated Depreciation
-
-
-220.85
-
-234.96
-
Long-term Investments
-
-
0.82
-
0.58
-
Accrued Expenses
-
-
39.44
-
37.94
-
Pension & Other Post Retirement Benefits
-
-
7.27
-
6.84
-

Fisher & Paykel Healthcare Corporation Limited (ASX FPH) Cashflow Statement

30/09/2018
30/06/2018
31/12/2017
30/06/2017
31/12/2016
30/06/2016
Net Income (Cashflow) ($m)
89.28
44.61
123.38
38.78
119.12
37.42
Depreciation & Amortization ($m)
19.16
9.57
29.31
11.21
26.82
9.52
Other Non-Cash Items, Total ($m)
-2.38
-1.19
1.59
-1.24
-0.10
1.05
Change in Net Operating Assets ($m)
-20.44
-10.21
-5.95
-9.54
-17.53
-11.53
Cash from Operations ($m)
85.62
42.78
149.96
39.21
129.90
36.46
Capital Expenditure ($m)
-49.22
-24.60
-57.85
-21.04
-33.99
-10.86
Other Investing Activities, Total ($m)
34.47
17.22
-55.89
-3.58
-11.03
-3.73
Cash from Investing ($m)
-14.76
-7.37
-113.65
-24.62
-44.92
-14.55
Total Debt Issued ($m)
12.92
6.46
23.68
9.87
-
-
Long Term Debt Issued ($m)
12.92
-
-
-
-
-
Total Debt Repaid ($m)
-10.36
-5.18
-6.09
-1.72
-
-
Long Term Debt Repaid ($m)
-10.36
-
-
-
-
-
Issuance of Common Stock ($m)
0.64
0.32
1.05
0.24
1.35
0.57
Total Dividends Paid ($m)
-58.12
-29.04
-67.98
-27.57
-61.73
-23.11
Cash from Financing ($m)
-54.91
-27.44
-54.21
-19.18
-64.95
-22.54
Foreign Exchange Rate Adjustments ($m)
0.92
0.46
-0.09
-0.10
-0.24
-0.33
Net Change in Cash ($m)
16.87
8.43
-18.00
-4.68
19.79
-0.96
Other Amortization
-
-
1.64
-
1.59
-
Sale of Property, Plant, and Equipment
-
-
0.09
-
0.10
0.05
Other Financing Activities, Total
-
-
-4.86
-
-4.57
-
Depreciation (From Notes)
-
-
24.27
-
22.97
7.42

Fisher & Paykel Healthcare Corporation Limited (ASX FPH) Income Statement

30/09/2018
30/06/2018
31/12/2017
30/06/2017
31/12/2016
30/06/2016
Revenues ($m)
468.69
234.20
654.00
218.68
635.36
203.47
Total Revenues ($m)
468.69
234.20
654.00
218.68
635.36
203.47
Cost Of Revenues ($m)
155.56
77.73
220.89
74.28
218.25
71.45
Gross Profit ($m)
313.13
156.47
433.11
144.40
417.10
132.03
Other Operating Expenses, Total ($m)
185.72
92.80
258.25
89.54
248.20
79.05
Selling General & Admin Expenses, Total ($m)
146.12
73.01
197.31
68.36
190.38
60.34
R & D Expenses ($m)
41.89
20.93
64.35
22.37
61.44
19.91
Other Operating Expenses ($m)
-2.29
-1.15
-3.41
-1.19
-3.61
-1.20
Operating Income ($m)
127.42
63.67
174.86
54.86
168.90
52.97
Net Interest Expenses ($m)
0.27
0.14
-1.45
-0.52
-2.50
-1.00
Interest Expense ($m)
-1.28
-0.64
-2.50
-0.86
-2.74
-1.05
Interest And Investment Income ($m)
1.56
0.78
1.05
0.33
0.24
0.05
Other Non-Operating Income/(Expenses), Total ($m)
-3.12
-1.56
0.14
0.10
1.97
1.24
EBT Excl. Unusual Items ($m)
124.57
62.25
173.54
54.43
168.37
53.21
EBT Incl Unusual Items ($m)
124.57
62.25
173.54
54.43
168.37
53.21
Income Tax Expense ($m)
35.29
17.64
50.17
15.65
49.26
15.79
Earnings From Continuing Operations ($m)
89.28
44.61
123.38
38.78
119.12
37.42
Net Income to Company ($m)
89.28
44.61
123.38
38.78
119.12
37.42
Net Income ($m)
89.28
44.61
123.38
38.78
119.12
37.42
Net Income to Common Incl Extra Items ($m)
89.28
44.61
123.38
38.78
119.12
37.42
EBITDA ($m)
146.57
73.24
204.17
66.07
195.72
62.50
Net Income to Common Excl Extra Items ($m)
89.28
44.61
123.38
38.78
119.12
37.42
Basic EPS
0.16
0.08
0.22
0.07
0.21
0.07
Basic EPS Excl Extra Items
0.16
0.08
0.22
0.07
0.21
0.07
Weighted Average Basic Shares Outstanding ($m)
572.06
572.06
569.69
569.03
565.75
564.99
Diluted EPS
0.15
0.08
0.21
0.07
0.21
0.07
Diluted EPS Excl Extra Items
0.15
0.08
0.21
0.07
0.21
0.07
Weighted Average Diluted Shares Outstanding ($m)
577.52
577.52
576.19
575.69
574.03
573.43
Normalized Basic EPS
0.14
0.07
0.19
0.06
0.19
0.06
Normalized Diluted EPS
0.13
0.07
0.19
0.06
0.18
0.06
Dividend per Share - Net
0.09
0.04
0.14
0.04
0.13
0.04

Top 5 Best Shares To Buy On The ASX In 2019

Our research team has worked hard to uncover 5 stocks that either have growth potential or are undervalued. These stocks represent some of the best value the ASX has to offer. Download your free report now!





Unsubscribe at any time. We won’t sell your details or spam, check privacy policy for more information.

Disclaimer

MF & Co. Asset Management has made every attempt to ensure the accuracy and reliability of the information on this page. However, the information is provided “as is” without any warranty of any kind. MF & Co. Asset Management does not accept any responsibility or liability of the accuracy, completeness, content, reliability or legality of the information.

No warranties, advice or representations of any kind, implied or expressed is given to the standard, nature, accuracy or otherwise of the information that is provided. All information is provided on a factual or general advice basis only and is not intended or be construed as an offer, solicitation, or a recommendation for any financial product unless expressly stated. You should seek professional investment advice before making any investment decision.